Our research emphasizes the importance of inflammation control in post-vaccination COVID-19 management by investigating C-type lectin mechanisms, particularly CLEC5A expression and inflammatory gene activation through in vitro, in vivo and in silico experiments [21,22]. The gene discussed is CLEC5A; the disease is COVID-19.